Literature DB >> 16169798

Peripheral inflammation in patients with asthmatic symptoms but normal lung function.

Lauri Lehtimäki1, Hannu Kankaanranta, Seppo Saarelainen, Väinö Turjanmaa, Eeva Moilanen.   

Abstract

Some patients with asthmatic symptoms and eosinophilic airway inflammation have normal lung function and thus do not meet the current diagnostic criteria of asthma. Exhaled nitric oxide (NO) measurement at multiple exhalation flow rates can be used to assess alveolar and bronchial NO output and inflammation. We tested whether alveolar or bronchial NO output is increased in subjects having asthmatic symptoms but normal lung function. Exhaled NO concentration was measured at three exhalation flow rates (100, 175, and 370 mL/s) to assess alveolar NO concentration and bronchial NO flux in 23 patients with asthmatic symptoms but normal lung function ("asthmatic symptoms group"), 40 patients with asthma, and 40 healthy control subjects. The asthmatic symptoms group had increased bronchial NO flux (1.7 +/- 0.3 nL/s, p = 0.016) and alveolar NO concentration (1.8 +/- 0.2 parts per billion (ppb), p = 0.010) compared with healthy controls (0.7 +/- 0.1 nL/s and 1.0 +/- 0.1 ppb, respectively). Patients with asthma had even higher bronchial NO flux (2.5 +/- 0.3 nL/s, p = 0.024) but normal alveolar NO concentration (1.1 +/- 0.2 ppb, p = 0.664). In asthmatic symptoms group, alveolar NO concentration correlated positively with blood eosinophil count and negatively with small airway function (FEF50% and FEF75%). In conclusion, patients with asthmatic symptoms but normal lung function have increased alveolar NO concentration and mildly elevated bronchial NO flux suggesting a more peripheral inflammation than in patients with asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169798     DOI: 10.1080/02770900500294678

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  9 in total

1.  Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.

Authors:  Hannele Lehtonen; Panu Oksa; Lauri Lehtimäki; Anna Sepponen; Riina Nieminen; Hannu Kankaanranta; Seppo Saarelainen; Ritva Järvenpää; Jukka Uitti; Eeva Moilanen
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

2.  Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma.

Authors:  Akihiko Ohwada; Kei Inami; Emi Onuma; Mariko Matsumoto-Yamazaki; Ryo Atsuta; Kazuhisa Takahashi
Journal:  Exp Ther Med       Date:  2011-05-12       Impact factor: 2.447

Review 3.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

Review 4.  Partitioned exhaled nitric oxide to non-invasively assess asthma.

Authors:  James L Puckett; Steven C George
Journal:  Respir Physiol Neurobiol       Date:  2008-07-31       Impact factor: 1.931

5.  Quantifying proximal and distal sources of NO in asthma using a multicompartment model.

Authors:  David A Shelley; James L Puckett; Steven C George
Journal:  J Appl Physiol (1985)       Date:  2010-01-21

6.  Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes.

Authors:  Bilun Gemicioglu; Benan Musellim; Ismail Dogan; Kasim Guven
Journal:  Allergy Rhinol (Providence)       Date:  2014-01

7.  Increased levels of alveolar and airway exhaled nitric oxide in runners.

Authors:  Alexandra Thornadtsson; Nikola Drca; Fabio Ricciardolo; Marieann Högman
Journal:  Ups J Med Sci       Date:  2017-05-08       Impact factor: 2.384

8.  Incense smoke: clinical, structural and molecular effects on airway disease.

Authors:  Ta-Chang Lin; Guha Krishnaswamy; David S Chi
Journal:  Clin Mol Allergy       Date:  2008-04-25

Review 9.  Small airway dysfunction and bronchial asthma control : the state of the art.

Authors:  Marcello Cottini; Carlo Lombardi; Claudio Micheletto
Journal:  Asthma Res Pract       Date:  2015-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.